Dogan Ozlem a , Ali Murat Sedef b,* , Fatih Kose b , Ozgur Ozyilkan b
a Baskent University, Department of Internal Medicine, Ankara, Turkey
b Baskent University, Department of Medical Oncology, Ankara, Turkey
Doi: 10.1016/j.jons.2018.07.002 - Article's Language: EN
Journal of Oncological Sciences 4 (2018) 149-150
Introduction: Sweet syndrome (SS) characterized by papules, plaques or nodules. SS was divided into three subcategories as classical SS, malignancy associated SS, and drug-induced SS.
Case presentation: We present a case of G-CSF-associated Sweet Syndrome (SS) in a 50-year-old man with the diagnosis of extensive stage small cell lung cancer. We started preemptive methylprednisolone with a diagnosis of the sweet syndrome.
Conclusion: SS is the insidious complication of G-CSF . Clinical suspicion is the key to the early diagnosis.